{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:56:07Z","timestamp":1781510167866,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011482","name":"Yantai Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022YD050"],"award-info":[{"award-number":["2022YD050"]}],"id":[{"id":"10.13039\/501100011482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tranon.2026.102718","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:16:59Z","timestamp":1772471819000},"page":"102718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sohlh2 inhibited the angiogenesis of hepatocellular carcinoma through the HIF-1\u03b1\/VEGFA pathway"],"prefix":"10.1016","volume":"66","author":[{"given":"Qing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim. biophys. acta, Rev. cancer"},{"issue":"19","key":"10.1016\/j.tranon.2026.102718_bib0002","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3748\/wjg.v25.i19.2279","article-title":"Mechanisms of hepatocellular carcinoma progression","volume":"25","author":"Ogunwobi","year":"2019","journal-title":"World j. gastroenterol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102718_bib0003","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/gut.2008.152652","article-title":"Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC","volume":"58","author":"Calvisi","year":"2009","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.tranon.2026.102718_bib0004","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41388-022-02197-x","article-title":"PBLD inhibits angiogenesis via impeding VEGF\/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells","volume":"41","author":"Han","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-018-0727-1","article-title":"Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1\/2\/HIF-1\u03b1\/VEGFA signalling in hepatocellular carcinoma","volume":"37","author":"Lin","year":"2018","journal-title":"J. exp. clin. cancer res.: CR"},{"key":"10.1016\/j.tranon.2026.102718_bib0006","article-title":"The mechanisms of renin-angiotensin system in hepatocellular carcinoma: from the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures","volume":"141","author":"Zhang","year":"2021","journal-title":"Biomed. pharmacother. = Biomed. pharmacother."},{"issue":"9","key":"10.1016\/j.tranon.2026.102718_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156774","article-title":"HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy","volume":"132","author":"Salman","year":"2022","journal-title":"J. clin. investig."},{"key":"10.1016\/j.tranon.2026.102718_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221106820","article-title":"CLIC1 drives angiogenesis in hepatocellular carcinoma by modulating VEGFA","volume":"21","author":"Wei","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-024-03082-z","article-title":"CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis","volume":"43","author":"Zhang","year":"2024","journal-title":"J. exp. clin. cancer res.: CR"},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","article-title":"Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma","volume":"80","author":"Zhang","year":"2024","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","article-title":"Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies","volume":"20","author":"Yao","year":"2023","journal-title":"Cancer Biol. Med."},{"issue":"3","key":"10.1016\/j.tranon.2026.102718_bib0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. rev., Clinical oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal transduct. target. ther."},{"issue":"6","key":"10.1016\/j.tranon.2026.102718_bib0014","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/mc.22989","article-title":"Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt\/\u03b2-catenin signaling pathway","volume":"58","author":"Zhang","year":"2019","journal-title":"Mol. carcinog."},{"issue":"8","key":"10.1016\/j.tranon.2026.102718_bib0015","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/carcin\/bgu113","article-title":"Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1","volume":"35","author":"Zhang","year":"2014","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.tranon.2026.102718_bib0016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1158\/1541-7786.MCR-22-0134","article-title":"Sohlh2 regulates the stemness and differentiation of colon cancer stem cells by downregulating LncRNA-H19 transcription","volume":"21","author":"Zhang","year":"2023","journal-title":"Mol. cancer res.: MCR"},{"issue":"9","key":"10.1016\/j.tranon.2026.102718_bib0017","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1158\/1541-7786.MCR-20-0771","article-title":"SOHLH2 suppresses angiogenesis by downregulating HIF1\u03b1 expression in breast cancer","volume":"19","author":"Cui","year":"2021","journal-title":"Mol. cancer res.: MCR"},{"issue":"4","key":"10.1016\/j.tranon.2026.102718_bib0018","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/wrr.12708","article-title":"Roxadustat promotes angiogenesis through HIF-1\u03b1\/VEGF\/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats","volume":"27","author":"Zhu","year":"2019","journal-title":"Wound repair regen.: off. publ. Wound Heal. Soc. [and] Eur. Tissue Repair Soc."},{"issue":"3","key":"10.1016\/j.tranon.2026.102718_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031475","article-title":"BMP9-ID1 signaling activates HIF-1\u03b1 and VEGFA expression to promote tumor angiogenesis in hepatocellular carcinoma","volume":"23","author":"Chen","year":"2022","journal-title":"Int. j. mol. sci."},{"issue":"11","key":"10.1016\/j.tranon.2026.102718_bib0020","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/cac2.12364","article-title":"Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2022","journal-title":"Cancer commun. (Lond. Engl.)"},{"issue":"4","key":"10.1016\/j.tranon.2026.102718_bib0021","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41418-019-0449-8","article-title":"A novel LncRNA HITT forms a regulatory loop with HIF-1\u03b1 to modulate angiogenesis and tumor growth","volume":"27","author":"Wang","year":"2020","journal-title":"Cell death differ."},{"issue":"2","key":"10.1016\/j.tranon.2026.102718_bib0022","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1515\/hsz-2019-0119","article-title":"Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1\u03b1\/CA9 signaling pathway","volume":"401","author":"Zhang","year":"2020","journal-title":"Biol. chem."},{"key":"10.1016\/j.tranon.2026.102718_bib0023","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.2147\/OTT.S227215","article-title":"Cobalt chloride induced apoptosis by inhibiting GPC3 expression via the HIF-1\u03b1\/c-Myc axis in HepG2 cells","volume":"12","author":"Tong","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.tranon.2026.102718_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175154","article-title":"The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1\u03b1\/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo","volume":"930","author":"Xu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102718_bib0025","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.15252\/embr.201540107","article-title":"Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis","volume":"16","author":"Madsen","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tranon.2026.102718_bib0026","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero","year":"2015","journal-title":"Eur. j. pharm. biopharm.: off. j. Arbeitsgemeinschaft fur Pharm. Verfahrenstechnik e.V"},{"issue":"16","key":"10.1016\/j.tranon.2026.102718_bib0027","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1158\/0008-5472.CAN-08-0742","article-title":"Focal gains of VEGFA and molecular classification of hepatocellular carcinoma","volume":"68","author":"Chiang","year":"2008","journal-title":"Cancer res."},{"issue":"6","key":"10.1016\/j.tranon.2026.102718_bib0028","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","article-title":"Pivotal role of mTOR signaling in hepatocellular carcinoma","volume":"135","author":"Villanueva","year":"2008","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.tranon.2026.102718_bib0029","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1535-7163.MCT-06-0720","article-title":"Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer","volume":"6","author":"Stock","year":"2007","journal-title":"Mol. cancer ther."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4652(199804)175:1<10::AID-JCP2>3.0.CO;2-F","volume":"175","author":"Thoresen","year":"1998","journal-title":"J. cell. physiol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102718_bib0031","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/0008-5472.CAN-07-2460","article-title":"Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells","volume":"68","author":"Fuchs","year":"2008","journal-title":"Cancer res."},{"issue":"12","key":"10.1016\/j.tranon.2026.102718_bib0032","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41419-023-06383-x","article-title":"TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.tranon.2026.102718_bib0033","article-title":"Sohlh2 inhibits the malignant progression of renal cell carcinoma by upregulating klotho via DNMT3a","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102718_bib0034","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/mc.22355","article-title":"Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9","volume":"55","author":"Zhang","year":"2016","journal-title":"Mol. carcinog."},{"issue":"4","key":"10.1016\/j.tranon.2026.102718_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41408-021-00468-6","article-title":"Germline variants at SOHLH2 influence multiple myeloma risk","volume":"11","author":"Duran-Lozano","year":"2021","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer discov."},{"issue":"11","key":"10.1016\/j.tranon.2026.102718_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109253","article-title":"Tumor vessel co-option probed by single-cell analysis","volume":"35","author":"Teuwen","year":"2021","journal-title":"Cell reports"},{"issue":"11","key":"10.1016\/j.tranon.2026.102718_bib0038","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J. clin. investig."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0039","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2008.02.028","article-title":"Reactive oxygen species and HIF-1 signalling in cancer","volume":"266","author":"Galanis","year":"2008","journal-title":"Cancer letters"},{"issue":"10","key":"10.1016\/j.tranon.2026.102718_bib0040","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2-VEGF axis in renal cell carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat. med."},{"issue":"2","key":"10.1016\/j.tranon.2026.102718_bib0041","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15028107","article-title":"Association between the expression of HIF-1\u03b1 and VEGF and prognostic implications in primary liver cancer","volume":"15","author":"Guo","year":"2016","journal-title":"Genet. mol. res.: GMR"},{"issue":"5","key":"10.1016\/j.tranon.2026.102718_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16292","article-title":"Combined treatment with Alhagi maurorum and docetaxel inhibits breast cancer progression via targeting HIF-1\u03b1\/VEGF mediated tumor angiogenesis in vivo","volume":"9","author":"Bahamin","year":"2023","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.tranon.2026.102718_bib0043","first-page":"656","article-title":"[Expression and clinical significance of HIF-1a protein in hepatocellular carcinoma tissues]","volume":"12","author":"Ding","year":"2004","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chin. j. hepatol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102718_bib0044","first-page":"931","article-title":"Dexmedetomidine promotes angiogenesis and vasculogenic mimicry in human hepatocellular carcinoma through \u03b1 (2)-AR\/HIF-1\u03b1\/VEGFA Pathway","volume":"35","author":"Fang","year":"2022","journal-title":"Biomed. environ. sci.: BES"},{"key":"10.1016\/j.tranon.2026.102718_bib0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphar.2020.00460","article-title":"Dandelion polysaccharide exerts anti-angiogenesis effect on hepatocellular carcinoma by regulating VEGF\/HIF-1\u03b1 expression","volume":"11","author":"Ren","year":"2020","journal-title":"Front. pharmacol."},{"key":"10.1016\/j.tranon.2026.102718_bib0046","article-title":"Exosomal miR-3682-3p suppresses angiogenesis by targeting ANGPT1 via the RAS-MEK1\/2-ERK1\/2 pathway in hepatocellular carcinoma","volume":"9","author":"Dong","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102718_bib0047","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13576","article-title":"Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma","volume":"57","author":"Liang","year":"2024","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0048","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s12672-025-03201-y","article-title":"Deciphering hypoxia's role in hepatocellular carcinoma prognosis with single-cell approaches","volume":"16","author":"Liang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102718_bib0049","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41698-024-00564-3","article-title":"Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma","volume":"8","author":"Fan","year":"2024","journal-title":"NPJ Precis. Oncol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:48:36Z","timestamp":1781509716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"alternative-id":["S1936523326000550"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102718","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sohlh2 inhibited the angiogenesis of hepatocellular carcinoma through the HIF-1\u03b1\/VEGFA pathway","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102718"}}